JP2008512992A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512992A5
JP2008512992A5 JP2007531547A JP2007531547A JP2008512992A5 JP 2008512992 A5 JP2008512992 A5 JP 2008512992A5 JP 2007531547 A JP2007531547 A JP 2007531547A JP 2007531547 A JP2007531547 A JP 2007531547A JP 2008512992 A5 JP2008512992 A5 JP 2008512992A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
subject
tumor
c57bl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007531547A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512992A (ja
JP4980220B2 (ja
Filing date
Publication date
Priority claimed from BRPI0406057-1A external-priority patent/BRPI0406057B1/pt
Application filed filed Critical
Publication of JP2008512992A publication Critical patent/JP2008512992A/ja
Publication of JP2008512992A5 publication Critical patent/JP2008512992A5/ja
Application granted granted Critical
Publication of JP4980220B2 publication Critical patent/JP4980220B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007531547A 2004-09-15 2005-09-15 Kunitz型組換え阻害因子 Expired - Fee Related JP4980220B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BRPI0406057-1A BRPI0406057B1 (pt) 2004-09-15 2004-09-15 Sequência nucleotídica de um inibidor de proteases do tipo kunitz obtida a partir de uma biblioteca de cdna de glândulas salivarares de carrapatos amblyomma cajennese uso da proteína recombinante
BRPI0406057-1 2004-09-15
PCT/BR2005/000185 WO2006029492A1 (en) 2004-09-15 2005-09-15 Kunitz-type recombinant inhibitor.

Publications (3)

Publication Number Publication Date
JP2008512992A JP2008512992A (ja) 2008-05-01
JP2008512992A5 true JP2008512992A5 (enExample) 2008-10-30
JP4980220B2 JP4980220B2 (ja) 2012-07-18

Family

ID=36273230

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007531547A Expired - Fee Related JP4980220B2 (ja) 2004-09-15 2005-09-15 Kunitz型組換え阻害因子

Country Status (10)

Country Link
US (1) US8440795B2 (enExample)
EP (1) EP1799707B1 (enExample)
JP (1) JP4980220B2 (enExample)
CN (1) CN101142232B (enExample)
AU (1) AU2005284615B2 (enExample)
BR (1) BRPI0406057B1 (enExample)
CA (2) CA2581001C (enExample)
DK (1) DK1799707T3 (enExample)
ES (1) ES2410160T3 (enExample)
WO (1) WO2006029492A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0406057B1 (pt) 2004-09-15 2021-10-26 União Química Farmacêutica Nacional S/A Sequência nucleotídica de um inibidor de proteases do tipo kunitz obtida a partir de uma biblioteca de cdna de glândulas salivarares de carrapatos amblyomma cajennese uso da proteína recombinante
AU2008226358A1 (en) * 2007-03-14 2008-09-18 Ana Marisa Chudzinski-Tavassi Kunitz-type recombinant inhibitor
EP2379096B1 (en) * 2008-12-19 2019-10-30 Baxalta GmbH Tfpi inhibitors and methods of use
WO2010107991A2 (en) 2009-03-18 2010-09-23 Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Use of ixolaris, a tissue factor inhibitor, for the treatment and prevention of cancer
BR102018074043A2 (pt) * 2018-11-22 2020-06-02 Inst Butantan composto para a modulação de vias de rlr, tlr, oas e/ou oncostatina m, uso do mesmo para a preparação de um medicamento, composição e método para modulação das ditas vias
BR102018074037A2 (pt) * 2018-11-22 2021-05-11 Inst Butantan composto para direcionar entidades moleculares para o domínio intracelular de células neoplásicas, ingrediente farmacêutico ativo compreendendo o referido composto, composição farmacêutica, método para o diagnóstico, prognóstico e/ou tratamento de câncer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3006207C2 (de) * 1980-02-15 1982-10-21 Siemens AG, 1000 Berlin und 8000 München Elektrische Maschine mit einem Ständerblechpaket aus kornorientierten Blechen
DE3819078A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie
BRPI0406057B1 (pt) 2004-09-15 2021-10-26 União Química Farmacêutica Nacional S/A Sequência nucleotídica de um inibidor de proteases do tipo kunitz obtida a partir de uma biblioteca de cdna de glândulas salivarares de carrapatos amblyomma cajennese uso da proteína recombinante

Similar Documents

Publication Publication Date Title
JP2013027391A5 (enExample)
JP2018537089A5 (enExample)
JP2015504675A5 (enExample)
US20050143317A1 (en) Compounds and methods for treatment of thrombosis
JP2006516189A5 (enExample)
Bahia et al. Tumor necrosis factor alpha converting enzyme: an encouraging target for various inflammatory disorders
JP2014518641A5 (enExample)
JP2009511482A5 (enExample)
JP2017505114A5 (enExample)
CN1448392A (zh) 一类甲硫氨酰氨肽酶抑制剂
JP2022180437A5 (enExample)
JP2005528124A5 (enExample)
CA2576069A1 (en) Detoxifizyme with activity of transforming aflatoxin and the gene encodes thereof
JP2009509553A5 (enExample)
CN117402900A (zh) 番茄潜叶蛾葡聚糖酶Beita基因及其防治番茄潜叶蛾的应用
CN101623498A (zh) 基于肿瘤内皮标记物-8基因的双靶标肿瘤疫苗及其制备方法
CN102776217A (zh) 一种提高l-5-甲基四氢叶酸累积量的生物合成方法
JP2004532037A5 (enExample)
JP2012507308A5 (enExample)
JP2009507474A5 (enExample)
JP2016533190A5 (enExample)
JP2008537675A5 (enExample)
JP4980220B2 (ja) Kunitz型組換え阻害因子
CN1164753C (zh) 抗iv型胶原酶单链抗体与力达霉素辅基蛋白的融合蛋白
CN102146433A (zh) 用于指导伊立替康类药物个体化治疗的基因组合